WallStreetZenWallStreetZen

NYSE: BFLY
Butterfly Network Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BFLY stock forecasts and price targets.

Forecast return on equity

Is BFLY forecast to generate an efficient return?

Company
N/A
Industry
23.06%
Market
61.99%

Forecast return on assets

Is BFLY forecast to generate an efficient return on assets?

Company
N/A
Industry
12.28%

BFLY earnings per share forecast

What is BFLY's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.32
Avg 2 year Forecast
-$0.29

BFLY revenue forecast

What is BFLY's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$97.5M+18.87%
Avg 2 year Forecast
$122.9M+49.73%
Avg 3 year Forecast
$137.4M+67.4%
BFLY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BFLY revenue growth forecast

How is BFLY forecast to perform vs Medical Devices companies and vs the US market?

Company
20.81%
Industry
8.1%
Market
10.68%
BFLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BFLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BFLY vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BFLY$2.29N/AN/A
AVNS$12.08N/AN/A
SIBN$13.45$25.75+91.45%Strong Buy
RXST$14.20$30.88+117.43%Hold
CBLL$14.93$33.00+121.03%Strong Buy
View Top Medical Device Stocks

Butterfly Network Stock Forecast FAQ

What is BFLY's earnings growth forecast for 2025-2026?

(NYSE: BFLY) Butterfly Network's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.

Butterfly Network's earnings in 2025 is -$72,492,000.On average, 2 Wall Street analysts forecast BFLY's earnings for 2025 to be -$76,520,793, with the lowest BFLY earnings forecast at -$80,164,640, and the highest BFLY earnings forecast at -$72,876,945.

In 2026, BFLY is forecast to generate -$70,447,714 in earnings, with the lowest earnings forecast at -$72,876,945 and the highest earnings forecast at -$68,018,482.

If you're new to stock investing, here's how to buy Butterfly Network stock.

What is BFLY's revenue growth forecast for 2025-2027?

(NYSE: BFLY) Butterfly Network's forecast annual revenue growth rate of 20.81% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.68%.

Butterfly Network's revenue in 2025 is $82,056,000.On average, 2 Wall Street analysts forecast BFLY's revenue for 2025 to be $23,694,724,149, with the lowest BFLY revenue forecast at $23,558,687,184, and the highest BFLY revenue forecast at $23,830,761,113. On average, 2 Wall Street analysts forecast BFLY's revenue for 2026 to be $29,845,538,332, with the lowest BFLY revenue forecast at $28,033,331,625, and the highest BFLY revenue forecast at $31,657,745,038.

In 2027, BFLY is forecast to generate $33,367,924,021 in revenue, with the lowest revenue forecast at $33,367,924,021 and the highest revenue forecast at $33,367,924,021.

What is BFLY's forecast return on assets (ROA) for 2025-2027?

(NYSE: BFLY) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.28%.

What is BFLY's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSE: BFLY) Butterfly Network's current Earnings Per Share (EPS) is -$0.34. On average, analysts forecast that BFLY's EPS will be -$0.32 for 2025, with the lowest EPS forecast at -$0.33, and the highest EPS forecast at -$0.30. In 2026, BFLY's EPS is forecast to hit -$0.29 (min: -$0.30, max: -$0.28).

What is BFLY's forecast return on equity (ROE) for 2025-2027?

(NYSE: BFLY) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.